Medicaments for the treatment of chronic obstructive pulmonary disease


Ontology type: sgo:Patent     


Patent Info

DATE

2010-08-31T00:00

AUTHORS

KONETZKI INGO , SCHROMM KURT , SCHOLLENBERGER HERMANN , PESTEL SABINE , SCHNAPP ANDREAS , BOUYSSOU THIERRY , BUETTNER FRANK , HEINE CLAUDIA , RUDOLF KLAUS , LUSTENBERGER PHILIPP , HOENKE CHRISTOPH

ABSTRACT

A pharmaceutical composition comprising a compound of formula 1 wherein: n is 1 or 2;R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, oran acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; anda pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/40", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/34", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "KONETZKI INGO", 
        "type": "Person"
      }, 
      {
        "name": "SCHROMM KURT", 
        "type": "Person"
      }, 
      {
        "name": "SCHOLLENBERGER HERMANN", 
        "type": "Person"
      }, 
      {
        "name": "PESTEL SABINE", 
        "type": "Person"
      }, 
      {
        "name": "SCHNAPP ANDREAS", 
        "type": "Person"
      }, 
      {
        "name": "BOUYSSOU THIERRY", 
        "type": "Person"
      }, 
      {
        "name": "BUETTNER FRANK", 
        "type": "Person"
      }, 
      {
        "name": "HEINE CLAUDIA", 
        "type": "Person"
      }, 
      {
        "name": "RUDOLF KLAUS", 
        "type": "Person"
      }, 
      {
        "name": "LUSTENBERGER PHILIPP", 
        "type": "Person"
      }, 
      {
        "name": "HOENKE CHRISTOPH", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002018-200427100-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048743769", 
          "https://doi.org/10.2165/00002018-200427100-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-200427040-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008046870", 
          "https://doi.org/10.2165/00002018-200427040-00003"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-08-31T00:00", 
    "description": "

A pharmaceutical composition comprising a compound of formula 1

\n

\"embedded
\nwherein:\n

  • n is 1 or 2;
  • R1 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R2 is hydrogen, C1-C4-alkyl, halogen, OH, or —O—C1-C4-alkyl;
  • R3 is hydrogen, C1-C4-alkyl, OH, halogen, —O—C1-C4-alkyl, —O—C1-C4-alkylene-COOH, or —O—C1-C4-alkylene-CO—O—C1-C4-alkyl, or
  • an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and
  • a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).

", "endDate": "2023-11-10", "id": "sg:patent.US-7786111-B2", "name": "Medicaments for the treatment of chronic obstructive pulmonary disease", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.420061.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-7786111-B2" ], "sdDataset": "patents", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/patent/patent_14.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-7786111-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-7786111-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-7786111-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-7786111-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

77 TRIPLES      15 PREDICATES      19 URIs      9 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-7786111-B2 schema:about anzsrc-for:34
2 anzsrc-for:3402
3 anzsrc-for:40
4 schema:author N9e397c4c495042f8b29ce4d98b449e17
5 schema:citation sg:pub.10.2165/00002018-200427040-00003
6 sg:pub.10.2165/00002018-200427100-00001
7 schema:datePublished 2010-08-31T00:00
8 schema:description <p num="p-0001">A pharmaceutical composition comprising a compound of formula 1</p> <p num="p-0002"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="29.80mm" wi="71.88mm" file="US07786111-20100831-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US07786111-20100831-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US07786111-20100831-C00001.MOL"/></attachments></chemistry><br/> wherein: <ul><li id="ul0001-0001" num="0000">n is 1 or 2;</li><li id="ul0001-0002" num="0000">R<sup>1 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0003" num="0000">R<sup>2 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, halogen, OH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl;</li><li id="ul0001-0004" num="0000">R<sup>3 </sup>is hydrogen, C<sub>1</sub>-C<sub>4</sub>-alkyl, OH, halogen, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-COOH, or &#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkylene-CO&#8212;O&#8212;C<sub>1</sub>-C<sub>4</sub>-alkyl, or</li><li id="ul0001-0005" num="0000">an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and</li><li id="ul0001-0006" num="0000">a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD).</li></ul></p>
9 schema:endDate 2023-11-10
10 schema:name Medicaments for the treatment of chronic obstructive pulmonary disease
11 schema:recipient grid-institutes:grid.420061.1
12 schema:sameAs https://app.dimensions.ai/details/patent/US-7786111-B2
13 schema:sdDatePublished 2022-12-01T06:58
14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
15 schema:sdPublisher N98c8e0ab13834f4c9b1680d88941bfb0
16 sgo:license sg:explorer/license/
17 sgo:sdDataset patents
18 rdf:type sgo:Patent
19 N065d04afa0de4911ad89538fcc4c75c8 rdf:first Nbe57d8717cdc4486be1ad2d59759289e
20 rdf:rest N2801a7d679714b4690acc363f4145e43
21 N100f8d8459d2462cb59cbafaf76e43bc rdf:first Nd66f3988237b4fcba40939eb1ba2746f
22 rdf:rest N065d04afa0de4911ad89538fcc4c75c8
23 N1105a34589944970a46241b88309e30d rdf:first Ne381748351534486a98511abe7d87e5c
24 rdf:rest rdf:nil
25 N2801a7d679714b4690acc363f4145e43 rdf:first Nc1e46fdaec0748f0aed5579a2de1b117
26 rdf:rest Nfb9130586bff4c3f8fcccf9713d94551
27 N2acf0ec026354bdc9af3844b9e6ee4e8 rdf:first N7a8c76474a13467cb49a03cd3578dd0e
28 rdf:rest Na558b54d72b74fc4a895e28d5bb504bf
29 N41354108ef0742f091ba80f9d1e10d6a schema:name KONETZKI INGO
30 rdf:type schema:Person
31 N4fcaf59e033e4a8dbda894387041a18f schema:name PESTEL SABINE
32 rdf:type schema:Person
33 N73788b561740456fae06612f4d67bf5e rdf:first N4fcaf59e033e4a8dbda894387041a18f
34 rdf:rest N100f8d8459d2462cb59cbafaf76e43bc
35 N7a8c76474a13467cb49a03cd3578dd0e schema:name SCHROMM KURT
36 rdf:type schema:Person
37 N85a0f6e9760c47eaa6becaa56980bd58 rdf:first Nd3454430c3d44dd1982881cc7e951964
38 rdf:rest Nae6e45d204044242a641335b82ff1946
39 N98c8e0ab13834f4c9b1680d88941bfb0 schema:name Springer Nature - SN SciGraph project
40 rdf:type schema:Organization
41 N9e397c4c495042f8b29ce4d98b449e17 rdf:first N41354108ef0742f091ba80f9d1e10d6a
42 rdf:rest N2acf0ec026354bdc9af3844b9e6ee4e8
43 Na558b54d72b74fc4a895e28d5bb504bf rdf:first Nc0564f44cfaa47e384a64dd44dd06a2d
44 rdf:rest N73788b561740456fae06612f4d67bf5e
45 Nac0e72759e564b319ac7c1fe797193a3 schema:name HEINE CLAUDIA
46 rdf:type schema:Person
47 Nae6e45d204044242a641335b82ff1946 rdf:first Nb4f997575417495cbac58738dd2db923
48 rdf:rest N1105a34589944970a46241b88309e30d
49 Nb4f997575417495cbac58738dd2db923 schema:name LUSTENBERGER PHILIPP
50 rdf:type schema:Person
51 Nbe57d8717cdc4486be1ad2d59759289e schema:name BOUYSSOU THIERRY
52 rdf:type schema:Person
53 Nc0564f44cfaa47e384a64dd44dd06a2d schema:name SCHOLLENBERGER HERMANN
54 rdf:type schema:Person
55 Nc1e46fdaec0748f0aed5579a2de1b117 schema:name BUETTNER FRANK
56 rdf:type schema:Person
57 Nd3454430c3d44dd1982881cc7e951964 schema:name RUDOLF KLAUS
58 rdf:type schema:Person
59 Nd66f3988237b4fcba40939eb1ba2746f schema:name SCHNAPP ANDREAS
60 rdf:type schema:Person
61 Ne381748351534486a98511abe7d87e5c schema:name HOENKE CHRISTOPH
62 rdf:type schema:Person
63 Nfb9130586bff4c3f8fcccf9713d94551 rdf:first Nac0e72759e564b319ac7c1fe797193a3
64 rdf:rest N85a0f6e9760c47eaa6becaa56980bd58
65 anzsrc-for:34 schema:inDefinedTermSet anzsrc-for:
66 rdf:type schema:DefinedTerm
67 anzsrc-for:3402 schema:inDefinedTermSet anzsrc-for:
68 rdf:type schema:DefinedTerm
69 anzsrc-for:40 schema:inDefinedTermSet anzsrc-for:
70 rdf:type schema:DefinedTerm
71 sg:pub.10.2165/00002018-200427040-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008046870
72 https://doi.org/10.2165/00002018-200427040-00003
73 rdf:type schema:CreativeWork
74 sg:pub.10.2165/00002018-200427100-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048743769
75 https://doi.org/10.2165/00002018-200427100-00001
76 rdf:type schema:CreativeWork
77 grid-institutes:grid.420061.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...